BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...in October with $108 million. Also participating in the series B were Surveyor Capital, Invus, Wellington Management...
...– Epidermal growth factor receptor 2 BC Staff CVnCoV CT-0508 (CARMA-0508) ARGX-113 (efgartigimod) Bayer AG CureVac N.V. Boxer Capital EcoR1 Capital Omega Funds Vida Ventures Surveyor Capital Invus Wellington Management OrbiMed Casdin...
BioCentury | Jan 8, 2021
Finance

Crossovers back Affinivax in $236M round as more pipeline vaccines move toward clinic

...mature pipeline.”Beyond the two lead investors, Affinivax’s latest round included new investors T. Rowe Price, Wellington Management...
BioCentury | Dec 18, 2020
Product Development

2021 Predictions: a BioCentury survey

...already begun to pursue biotech investments. Last year, Wellington Management...
BioCentury | Nov 5, 2020
Deals

Merck adds ROR1 to its pipeline, rewards VelosBio’s investors with $2.8B takeout

...Janus Henderson Investors, Logos Capital, OrbiMed Advisors, T. Rowe Price, Venrock, Viking Global Investors and Wellington Management...
BioCentury | Oct 30, 2020
Finance

Oct. 29 Quick Takes: Ultragenyx, Scholar Rock, Galecto, Citrine-Bioprojet, miRagen-Viridian, Elpis, CASI-BioInvent

...$91 million into the union; leader Fairmount Funds Management joins Venrock, BVF Partners, Cormorant, Perceptive Advisors, Wellington Management...
BioCentury | Oct 29, 2020
Finance

Perceptive-backed in-licensing play LianBio to cast a wide net with $310M crossover round

...Management, Vida Ventures, Viking Global Investors and Wellington Management.TARGETSSHP-2...
BioCentury | Oct 29, 2020
Finance

Oct. 28 Quick Takes: Mirati raises $800M on KRAS data; BMS-insitro, Novartis-Molecular Partners, Genecast, Gracell, PureTech, Cerevel, Biodesix

...$100MShanghai and Suzhou-based Gracell Biotechnologies Inc. raised a $100 million series C round led by Wellington Management...
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...Capital, Ally Bridge, Avidity Partners, Deerfield Management, Irving Investors, Monashee Investment Management, OrbiMed Advisors and Wellington Management...
BioCentury | Oct 2, 2020
Finance

Next stop IPO? Olema adds to momentum with $85M series C

...round. Its existing investors include BVF Partners, Logos Capital, Janus Henderson Investors, Cormorant Asset Management, Wellington Management...
BioCentury | Sep 15, 2020
Finance

Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more

...roundNeurodegenerative disease company Escape Bio Inc. raised $73 million in a crossover round led by Wellington Management...
Items per page:
1 - 10 of 118
BioCentury | Jan 8, 2021
Deals

Jan. 7 Quick Takes: Strong demand for Cullinan IPO; plus Bayer-CureVac COVID deal and venture rounds for Scorpion, Kira, Carisma and Abcuro and more

...in October with $108 million. Also participating in the series B were Surveyor Capital, Invus, Wellington Management...
...– Epidermal growth factor receptor 2 BC Staff CVnCoV CT-0508 (CARMA-0508) ARGX-113 (efgartigimod) Bayer AG CureVac N.V. Boxer Capital EcoR1 Capital Omega Funds Vida Ventures Surveyor Capital Invus Wellington Management OrbiMed Casdin...
BioCentury | Jan 8, 2021
Finance

Crossovers back Affinivax in $236M round as more pipeline vaccines move toward clinic

...mature pipeline.”Beyond the two lead investors, Affinivax’s latest round included new investors T. Rowe Price, Wellington Management...
BioCentury | Dec 18, 2020
Product Development

2021 Predictions: a BioCentury survey

...already begun to pursue biotech investments. Last year, Wellington Management...
BioCentury | Nov 5, 2020
Deals

Merck adds ROR1 to its pipeline, rewards VelosBio’s investors with $2.8B takeout

...Janus Henderson Investors, Logos Capital, OrbiMed Advisors, T. Rowe Price, Venrock, Viking Global Investors and Wellington Management...
BioCentury | Oct 30, 2020
Finance

Oct. 29 Quick Takes: Ultragenyx, Scholar Rock, Galecto, Citrine-Bioprojet, miRagen-Viridian, Elpis, CASI-BioInvent

...$91 million into the union; leader Fairmount Funds Management joins Venrock, BVF Partners, Cormorant, Perceptive Advisors, Wellington Management...
BioCentury | Oct 29, 2020
Finance

Perceptive-backed in-licensing play LianBio to cast a wide net with $310M crossover round

...Management, Vida Ventures, Viking Global Investors and Wellington Management.TARGETSSHP-2...
BioCentury | Oct 29, 2020
Finance

Oct. 28 Quick Takes: Mirati raises $800M on KRAS data; BMS-insitro, Novartis-Molecular Partners, Genecast, Gracell, PureTech, Cerevel, Biodesix

...$100MShanghai and Suzhou-based Gracell Biotechnologies Inc. raised a $100 million series C round led by Wellington Management...
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...Capital, Ally Bridge, Avidity Partners, Deerfield Management, Irving Investors, Monashee Investment Management, OrbiMed Advisors and Wellington Management...
BioCentury | Oct 2, 2020
Finance

Next stop IPO? Olema adds to momentum with $85M series C

...round. Its existing investors include BVF Partners, Logos Capital, Janus Henderson Investors, Cormorant Asset Management, Wellington Management...
BioCentury | Sep 15, 2020
Finance

Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more

...roundNeurodegenerative disease company Escape Bio Inc. raised $73 million in a crossover round led by Wellington Management...
Items per page:
1 - 10 of 118